The chief financial officer of Omnicell plans to step down sometime this year. The maker of automated medication-management systems said Wednesday that Nchacha Etta intends to depart on Sept. 15 or ...
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and ...
Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...
Omnicell (OMCL) announced that Nchacha Etta will be stepping down from his role as executive VP and CFO, effective September 15 or until a ...
BofA lowered the firm’s price target on Omnicell (OMCL) to $38 from $46 and keeps a Neutral rating on the shares after the company announced a ...
Omnicell stock opened at $36.99 on Thursday. The stock has a market cap of $1.73 billion, a P/E ratio of 137.01, a price-to-earnings-growth ratio of 7.53 and a beta of 0.85. The company has a ...
FORT WORTH, Texas, March 12, 2025--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in ...
(NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced that Nchacha Etta will be stepping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results